ATE243538T1 - Neues verfahren zur herstellung von mitteln zur oberflächenbehandlung - Google Patents

Neues verfahren zur herstellung von mitteln zur oberflächenbehandlung

Info

Publication number
ATE243538T1
ATE243538T1 AT99944936T AT99944936T ATE243538T1 AT E243538 T1 ATE243538 T1 AT E243538T1 AT 99944936 T AT99944936 T AT 99944936T AT 99944936 T AT99944936 T AT 99944936T AT E243538 T1 ATE243538 T1 AT E243538T1
Authority
AT
Austria
Prior art keywords
surface treatment
new method
treatment agents
producing surface
heparin
Prior art date
Application number
AT99944936T
Other languages
English (en)
Inventor
Elisabeth Scholander
Original Assignee
Carmeda Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Carmeda Ab filed Critical Carmeda Ab
Application granted granted Critical
Publication of ATE243538T1 publication Critical patent/ATE243538T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/006—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
    • C08B37/0063—Glycosaminoglycans or mucopolysaccharides, e.g. keratan sulfate; Derivatives thereof, e.g. fucoidan
    • C08B37/0075—Heparin; Heparan sulfate; Derivatives thereof, e.g. heparosan; Purification or extraction methods thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L33/00—Antithrombogenic treatment of surgical articles, e.g. sutures, catheters, prostheses, or of articles for the manipulation or conditioning of blood; Materials for such treatment
    • A61L33/0005—Use of materials characterised by their function or physical properties
    • A61L33/0011—Anticoagulant, e.g. heparin, platelet aggregation inhibitor, fibrinolytic agent, other than enzymes, attached to the substrate
    • A61L33/0029—Anticoagulant, e.g. heparin, platelet aggregation inhibitor, fibrinolytic agent, other than enzymes, attached to the substrate using an intermediate layer of polymer

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Materials Engineering (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Polymers & Plastics (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Surgery (AREA)
  • Epidemiology (AREA)
  • Biochemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Materials For Medical Uses (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
  • Steroid Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT99944936T 1998-09-09 1999-09-08 Neues verfahren zur herstellung von mitteln zur oberflächenbehandlung ATE243538T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
NO984143A NO984143L (no) 1998-09-09 1998-09-09 Ny prosess for å fremstille overflatemodifiserende stoffer
PCT/NO1999/000277 WO2000013718A1 (en) 1998-09-09 1999-09-08 New process for preparing surface modification substances

Publications (1)

Publication Number Publication Date
ATE243538T1 true ATE243538T1 (de) 2003-07-15

Family

ID=19902393

Family Applications (1)

Application Number Title Priority Date Filing Date
AT99944936T ATE243538T1 (de) 1998-09-09 1999-09-08 Neues verfahren zur herstellung von mitteln zur oberflächenbehandlung

Country Status (14)

Country Link
US (1) US6461665B1 (de)
EP (1) EP1112097B1 (de)
JP (1) JP4152075B2 (de)
KR (1) KR100669132B1 (de)
AT (1) ATE243538T1 (de)
AU (1) AU757913B2 (de)
BR (1) BR9913516B1 (de)
CA (1) CA2342991C (de)
DE (1) DE69909104T2 (de)
DK (1) DK1112097T3 (de)
ES (1) ES2203177T3 (de)
NO (1) NO984143L (de)
PT (1) PT1112097E (de)
WO (1) WO2000013718A1 (de)

Families Citing this family (97)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6254564B1 (en) 1998-09-10 2001-07-03 Percardia, Inc. Left ventricular conduit with blood vessel graft
SE515295C2 (sv) 1999-11-23 2001-07-09 Medicarb Ab Förfarande för framställning av konjugat av en biologiskt aktiv polysackarid och ett fast substrat, samt sådana konjugat
US20030229374A1 (en) * 2002-05-10 2003-12-11 Salviac Limited Embolic protection system
US6926965B2 (en) * 2002-09-11 2005-08-09 Novartis Ag LbL-coated medical device and method for making the same
US8071569B2 (en) * 2002-09-20 2011-12-06 Mousa Shaker A Oxidized heparin fractions and their use in inhibiting angiogenesis
US20050281857A1 (en) * 2004-05-25 2005-12-22 Heyer Toni M Methods and reagents for preparing biomolecule-containing coatings
US20060159650A1 (en) * 2005-01-14 2006-07-20 Bacterin, Inc. Composition and method for covalently coupling an antithrombotic substance and a hydrophilic polymer
DE102005003632A1 (de) 2005-01-20 2006-08-17 Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. Katheter für die transvaskuläre Implantation von Herzklappenprothesen
CA2630823C (en) 2005-12-13 2015-02-10 Exthera Ab Method for extracorporeal removal of a pathogenic microbe, an inflammatory cell or an inflammatory protein from blood
US8986713B2 (en) * 2006-05-12 2015-03-24 W. L. Gore & Associates, Inc. Medical device capable of being compacted and expanded having anti-thrombin III binding activity
US8021677B2 (en) 2006-05-12 2011-09-20 Gore Enterprise Holdings, Inc. Immobilized biologically active entities having a high degree of biological activity
US8496953B2 (en) * 2006-05-12 2013-07-30 W. L. Gore & Associates, Inc. Immobilized biologically active entities having a high degree of biological activity following sterilization
US9114194B2 (en) * 2006-05-12 2015-08-25 W. L. Gore & Associates, Inc. Immobilized biologically active entities having high biological activity following mechanical manipulation
CA2664299C (en) 2006-09-15 2016-01-19 Toray Industries, Inc. Substrate comprising an anticoagulant and a hydrophilic polymer and manufacturing method thereof
US20080200421A1 (en) 2007-02-21 2008-08-21 Zhao Jonathon Z Coating for a medical device having an anti-thrombotic conjugate
US20090281059A1 (en) 2007-02-21 2009-11-12 Robert Falotico Coating for a medical device having an anti-thrombotic conjugate
US9693841B2 (en) 2007-04-02 2017-07-04 Ension, Inc. Surface treated staples, sutures and dental floss and methods of manufacturing the same
US8114465B2 (en) * 2007-04-02 2012-02-14 Ension, Inc. Process for preparing a substrate coated with a biomolecule
US7896915B2 (en) 2007-04-13 2011-03-01 Jenavalve Technology, Inc. Medical device for treating a heart valve insufficiency
US8383156B2 (en) 2007-04-30 2013-02-26 Cordis Corporation Coating for a medical device having an anti-thrombotic conjugate
US8663148B2 (en) * 2007-06-18 2014-03-04 Exthera Medical Corporation Device and method for restoration of the condition of blood
WO2008155683A1 (en) 2007-06-18 2008-12-24 Firmenich Sa Malodor counteracting compositions and method for their use
US20090018646A1 (en) 2007-07-10 2009-01-15 Zhao Jonathon Z Coating Employing an Anti-Thrombotic Conjugate
US20090192079A1 (en) * 2007-10-09 2009-07-30 Genzyme Corporation Prolonged delivery of heparin-binding growth factors from heparin-derivatized collagen
ES2903231T3 (es) 2008-02-26 2022-03-31 Jenavalve Tech Inc Stent para el posicionamiento y anclaje de una prótesis valvular en un sitio de implantación en el corazón de un paciente
US9044318B2 (en) 2008-02-26 2015-06-02 Jenavalve Technology Gmbh Stent for the positioning and anchoring of a valvular prosthesis
GB0816783D0 (en) * 2008-09-15 2008-10-22 Carmeda Ab Immobilised biological entities
US7819914B2 (en) 2008-12-16 2010-10-26 Cordis Corporation Adhesion promoting primer for coated surfaces
US20100161039A1 (en) * 2008-12-23 2010-06-24 Vipul Dave Adhesion promoting temporary mask for coated surfaces
AU2010200316A1 (en) * 2009-01-30 2010-08-19 Cordis Corporation Reservoir Eluting Stent
AU2010215936B2 (en) 2009-02-21 2015-03-05 Covidien Lp Medical devices having activated surfaces
EP2398525B1 (de) * 2009-02-21 2012-12-05 Sofradim Production Medizinisches gerät mit abbauverlangsamender beschichtung
US8658707B2 (en) 2009-03-24 2014-02-25 W. L. Gore & Associates, Inc. Expandable functional TFE copolymer fine powder, the expanded functional products obtained therefrom and reaction of the expanded products
US9139669B2 (en) * 2009-03-24 2015-09-22 W. L. Gore & Associates, Inc. Expandable functional TFE copolymer fine powder, the expandable functional products obtained therefrom and reaction of the expanded products
US8591932B2 (en) * 2009-09-17 2013-11-26 W. L. Gore & Associates, Inc. Heparin entities and methods of use
US8758286B2 (en) 2009-12-01 2014-06-24 Exthera Medical Corporation Method for removing cytokines from blood with surface immobilized polysaccharides
RU2539566C2 (ru) 2009-12-24 2015-01-20 Торэй Индастриз, Инк. Гидрофильное полимерное соединение, имеющее антикоагулянтный эффект
GB201004101D0 (en) * 2010-03-12 2010-04-28 Carmeda Ab Immobilised biological entities
JP2013526388A (ja) 2010-05-25 2013-06-24 イエナバルブ テクノロジー インク 人工心臓弁、及び人工心臓弁とステントを備える経カテーテル搬送体内プロテーゼ
US9839540B2 (en) 2011-01-14 2017-12-12 W. L. Gore & Associates, Inc. Stent
US10166128B2 (en) 2011-01-14 2019-01-01 W. L. Gore & Associates. Inc. Lattice
WO2012112724A1 (en) 2011-02-15 2012-08-23 Exthera Medical, Llc Device and method for removal of blood-borne pathogens, toxins and inflammatory cytokines
US9415193B2 (en) 2011-03-04 2016-08-16 W. L. Gore & Associates, Inc. Eluting medical devices
US20120310210A1 (en) 2011-03-04 2012-12-06 Campbell Carey V Eluting medical devices
CN105664252B (zh) 2011-03-11 2019-11-19 W.L.戈尔及同仁股份有限公司 固定的生物实体的改进
TW201309354A (zh) 2011-06-23 2013-03-01 Toray Industries 醫療材料
TW201311774A (zh) 2011-06-23 2013-03-16 Toray Industries 具有抗血液凝固作用的疏水性高分子化合物
US9775933B2 (en) 2012-03-02 2017-10-03 W. L. Gore & Associates, Inc. Biocompatible surfaces and devices incorporating such surfaces
DK2861273T3 (da) 2012-06-13 2017-11-27 Exthera Medical Corp Anvendelse af heparin og kulhydrater til behandling af cancer.
US9283072B2 (en) 2012-07-25 2016-03-15 W. L. Gore & Associates, Inc. Everting transcatheter valve and methods
US10376360B2 (en) 2012-07-27 2019-08-13 W. L. Gore & Associates, Inc. Multi-frame prosthetic valve apparatus and methods
US9931193B2 (en) 2012-11-13 2018-04-03 W. L. Gore & Associates, Inc. Elastic stent graft
US9101469B2 (en) 2012-12-19 2015-08-11 W. L. Gore & Associates, Inc. Prosthetic heart valve with leaflet shelving
US9968443B2 (en) 2012-12-19 2018-05-15 W. L. Gore & Associates, Inc. Vertical coaptation zone in a planar portion of prosthetic heart valve leaflet
US9144492B2 (en) 2012-12-19 2015-09-29 W. L. Gore & Associates, Inc. Truncated leaflet for prosthetic heart valves, preformed valve
WO2014209782A1 (en) 2013-06-24 2014-12-31 Exthera Medical Corporation Blood filtration system containing mannose coated substrate
CN105491978A (zh) 2013-08-30 2016-04-13 耶拿阀门科技股份有限公司 用于假体瓣膜的径向可折叠框架及其制造方法
CN105705177B (zh) 2013-11-08 2019-10-22 艾克塞拉医疗公司 使用吸附介质诊断感染性疾病的方法
US9795721B2 (en) 2013-11-28 2017-10-24 Toray Industries, Inc. Antithrombotic material
WO2015080176A1 (ja) 2013-11-28 2015-06-04 東レ株式会社 抗血栓性材料
US10842918B2 (en) 2013-12-05 2020-11-24 W.L. Gore & Associates, Inc. Length extensible implantable device and methods for making such devices
BR112016018452A2 (pt) 2014-02-12 2018-06-26 Toray Industries vaso sanguíneo artificial.
US11839698B2 (en) 2014-03-13 2023-12-12 W. L. Gore & Associates, Inc. Drug composition and coating
DE15782250T1 (de) 2014-04-24 2017-08-10 Exthera Medical Corporation Verfahren zur Entfernung von Bakterien aus Blut unter Verwendung einer hohen Durchflussrate
US9827094B2 (en) 2014-09-15 2017-11-28 W. L. Gore & Associates, Inc. Prosthetic heart valve with retention elements
CA2959975A1 (en) 2014-09-22 2016-03-31 Exthera Medical Corporation Wearable hemoperfusion device
WO2016177562A1 (en) 2015-05-01 2016-11-10 Jenavalve Technology, Inc. Device and method with reduced pacemaker rate in heart valve replacement
EP3095509A1 (de) 2015-05-18 2016-11-23 Defymed Funktionalisierte membrane für biokünstliche organe
US10561766B2 (en) 2015-09-15 2020-02-18 W. L. Gore & Associates, Inc. Drug composition and coating
WO2017151797A1 (en) 2016-03-02 2017-09-08 Exthera Medical Corporation Method for treating drug intoxication
US11911551B2 (en) 2016-03-02 2024-02-27 Exthera Medical Corporation Method for treating drug intoxication
WO2017184153A1 (en) 2016-04-21 2017-10-26 W. L. Gore & Associates, Inc. Diametrically adjustable endoprostheses and associated systems and methods
JP7081749B2 (ja) 2016-05-13 2022-06-07 イエナバルブ テクノロジー インク 心臓弁プロテーゼ送達システム
CN109790259B (zh) 2016-09-30 2021-12-07 东丽株式会社 共聚物和使用其的医疗材料
MX2019004004A (es) 2016-10-07 2019-06-10 Toray Industries Tela tejida tubular.
EP3318294A1 (de) 2016-11-08 2018-05-09 Defymed Kit zur in situ-ausgabe einer verbindung von interesse
CN110392557A (zh) 2017-01-27 2019-10-29 耶拿阀门科技股份有限公司 心脏瓣膜模拟
BR112019016808A2 (pt) 2017-03-31 2020-04-07 Toray Industries estrutura cilíndrica
US10959842B2 (en) 2017-09-12 2021-03-30 W. L. Gore & Associates, Inc. Leaflet frame attachment for prosthetic valves
WO2019067219A1 (en) 2017-09-27 2019-04-04 W. L. Gore & Associates, Inc. PROSTHETIC VALVE WITH EXTENSIBLE FRAME AND ASSOCIATED SYSTEMS AND METHODS
CA3072781C (en) 2017-09-27 2022-07-05 W.L. Gore & Associates, Inc. Prosthetic valves with mechanically coupled leaflets
EP3694445B1 (de) 2017-10-13 2024-07-10 Edwards Lifesciences Corporation Teleskopische klappenprothese und freisetzungssystem
JP7052032B2 (ja) 2017-10-31 2022-04-11 ダブリュ．エル．ゴア アンド アソシエイツ，インコーポレイティド 組織内方成長を促進する医療用弁及び弁膜
KR20200112812A (ko) 2018-01-30 2020-10-05 도레이 카부시키가이샤 평직물, 그 제조 방법 및 스텐트 그래프트
WO2019170859A2 (en) 2018-03-09 2019-09-12 Carmeda Ab Improvements to immobilising biological entities
AU2019232163A1 (en) 2018-03-09 2020-09-03 Carmeda Ab Improvements to processes for immobilising biological entities
US12053381B2 (en) 2018-07-18 2024-08-06 W. L. Gore & Associates, Inc. Implantable medical device deployment system
AU2019354085A1 (en) 2018-10-03 2021-03-18 Carmeda Ab Immobilised biological entities
US20200179663A1 (en) 2018-12-11 2020-06-11 W. L. Gore & Associates, Inc. Medical devices for shunts, occluders, fenestrations and related systems and methods
CN113490452A (zh) 2018-12-21 2021-10-08 W.L.戈尔及同仁股份有限公司 可植入心脏传感器
US20220062513A1 (en) 2019-01-30 2022-03-03 Toray Industries, Inc. Medical base material for indwelling cardiovascular device
US11497601B2 (en) 2019-03-01 2022-11-15 W. L. Gore & Associates, Inc. Telescoping prosthetic valve with retention element
JP2022534191A (ja) 2019-05-16 2022-07-28 エクスセラ メディカル コーポレイション 内皮糖衣構造を調節するための方法
CN114727821A (zh) 2019-11-15 2022-07-08 W.L.戈尔及同仁股份有限公司 左心耳设备和方法
AU2021425045B2 (en) 2020-02-04 2024-05-23 W. L. Gore & Associates, Inc. Inflow / outflow cannula
EP3892259A1 (de) 2020-04-09 2021-10-13 Defymed Membranen für medizinische vorrichtungen
US20230157588A1 (en) 2020-04-09 2023-05-25 Defymed Membranes for Medical Devices

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE8200751L (sv) * 1982-02-09 1983-08-10 Olle Larm Forfarande for kovalent koppling for framstellning av konjugat och hervid erhallna produkter
US4600652A (en) * 1985-04-01 1986-07-15 Warner-Lambert Company Permanently bonded antithrombogenic polyurethane surface
US5049403A (en) * 1989-10-12 1991-09-17 Horsk Hydro A.S. Process for the preparation of surface modified solid substrates
IT1260136B (it) 1992-04-17 1996-03-28 Alfa Wassermann Spa Glicosaminoglicani semisintetici contenenti acido alfa-l-galatturonicosostituito con radicali nucleofili in posizione 3
US5679659A (en) 1995-08-22 1997-10-21 Medtronic, Inc. Method for making heparinized biomaterials
US6174326B1 (en) 1996-09-25 2001-01-16 Terumo Kabushiki Kaisha Radiopaque, antithrombogenic stent and method for its production

Also Published As

Publication number Publication date
US6461665B1 (en) 2002-10-08
ES2203177T3 (es) 2004-04-01
EP1112097B1 (de) 2003-06-25
AU5765299A (en) 2000-03-27
DE69909104T2 (de) 2004-04-08
CA2342991A1 (en) 2000-03-16
EP1112097A1 (de) 2001-07-04
NO984143L (no) 2000-03-10
DE69909104D1 (de) 2003-07-31
JP4152075B2 (ja) 2008-09-17
BR9913516B1 (pt) 2010-09-21
NO984143D0 (no) 1998-09-09
CA2342991C (en) 2009-01-27
KR100669132B1 (ko) 2007-01-17
JP2003507082A (ja) 2003-02-25
KR20010088799A (ko) 2001-09-28
AU757913B2 (en) 2003-03-13
PT1112097E (pt) 2003-11-28
WO2000013718A1 (en) 2000-03-16
BR9913516A (pt) 2001-06-05
DK1112097T3 (da) 2003-10-20

Similar Documents

Publication Publication Date Title
ATE243538T1 (de) Neues verfahren zur herstellung von mitteln zur oberflächenbehandlung
ATE279181T1 (de) Verwendung von 5ht-6 antagonisten zur behandlung adhd
DE69711034D1 (de) Wässrige fluorpolymerlösungen zur behandlung von harten oberflächen
ATE206289T1 (de) Verfahren zur herstellung von fischgelatine
ATE264689T1 (de) Herstellung von kollagen
DE69840126D1 (de) Verfahren zur prophylaxis oder behandlung von östrogen-abhängigen krankheiten
DE3584693D1 (de) Verfahren zur herstellung von kohlenstoffasern des pechtyps.
DE69929787D1 (de) Verfahren zur behandlung von neurologischen erkrankungen mit hilfe der bestimmung des bche genotyps
DE3750714D1 (de) Verfahren zur Behandlung von Kohlenstoffasern mit Urethanen.
DE69013826D1 (de) Verfahren zur Herstellung von quaternisiertem Imidazolin, geeignet für die Behandlung von Textilien.
ATE289816T1 (de) Verwendung von mirtazapine zur herstellung eines medikaments zur behandlung von schlafapnoen
DE69015086D1 (de) Verfahren zur Behandlung von mit Messing beschichtetem Stahldraht.
ATE261454T1 (de) Verfahren zur herstellung von vernetzter hyaluronsäure
DE60044504D1 (de) Verfahren zur modifizierung von faserstoff auf cellulosebasis
DE69911644D1 (de) Verfahren zur entwässerung organischer flüssigkeiten
DE69519799D1 (de) Verfahren zur herstellung von [s,s]-ethylendiamin-n,n'-dibernsteinsäure
ATE204023T1 (de) Enzymatische verfahren zur herstellung von (s)- cyanhydrinen
DE3781279D1 (de) Verfahren zur behandlung von blut.
ATE82566T1 (de) Verfahren zur herstellung von alpha-(1methylethyl)-3,4-dimethoxybenzeneacetonitril.
DE69510798D1 (de) Verfahren zur herstellung von kalziumsalzen von [s,s]-äthylendiamin- n,n'-dibernsteinsäure
DE59910794D1 (de) Verfahren zur Behandlung von Cellulosefasern
UA26438A (uk) СПОСІБ ОТРИМАHHЯ СУЛЬФОHІЛФЕHІЛ- БЕttА-D-ТІОКСИЛОЗИДІВ
DE59000635D1 (de) Verfahren zur herstellung von natriummonosulfid.
DE3370498D1 (en) Process for the anti-felt treatment of keratinous fibres consisting of a basic oxidation catalyzed by a metal salt, and fibres obtained according to the process
DE3761824D1 (de) Verfahren zur herstellung von vanadiumtrichlorid in waessriger loesung.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1112097

Country of ref document: EP